SuperworthChampions Oncology shares outstanding CSBR
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Apr 30, 2026
- 13.9M
- On a year earlier
- +1.0%
- more shares
Champions Oncology had 13.9M diluted shares outstanding on average in Q4 FY26, the quarter to Apr 30, 2026.
That is 1.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 13.9M | +1% |
| FY2025 | 13.8M | +2% |
| FY2024 | 13.6M | +0% |
| FY2023 | 13.6M | +2% |
| FY2022 | 13.3M | −3% |
| FY2021 | 13.6M | +97% |
| FY2020 | 6.9M | −40% |
| FY2019 | 11.6M | +5% |
| FY2018 | 11M | −11% |
| FY2017 | 12.4M | +43% |
| FY2016 | 8.7M | +19% |
| FY2015 | 7.3M | +30% |
| FY2014 | 5.6M | +0% |
| FY2013 | 5.6M | +44% |
| FY2012 | 3.9M | +66% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 13.9M | +1% | |
| Q3 FY26 | 13.9M | −3% | |
| Q2 FY26 | 14.5M | +3% | |
| Q1 FY26 | 13.8M | −2% | |
| Q4 FY25 | 13.8M | +2% | |
| Q3 FY25 | 14.4M | +6% | |
| Q2 FY25 | 14M | +4% | |
| Q1 FY25 | 14M | +4% | |
| Q4 FY24 | 13.6M | +0% | |
| Q3 FY24 | 13.6M | +0% | |
| Q2 FY24 | 13.5M | −0% | |
| Q1 FY24 | 13.5M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Champions Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.